How Much PT-141 Should You Take? A Practical Dosing Guide

PT-141 at a glance:

• Drug class: Melanocortin receptor agonist
• Route: subcutaneous injection
• Typical frequency: as needed before sexual activity (no more than 1 dose/24h, no more than 8/month)
• Half-life: approximately 2.7 hours
• Cash price (US): $300-$1,000/month depending on dose frequency and pharmacy

Here's the core rule for PT-141 dosing: titrate slowly, hold each step long enough, and don't try to outpace your body. Approved adult dose is 1.

Standard Dosing Schedule for PT-141

Approved adult dose is 1.75 mg subcutaneously at least 45 minutes before anticipated sexual activity.

The typical schedule for PT-141 is as needed before sexual activity (no more than 1 dose/24h, no more than 8/month) via subcutaneous injection. Half-life of approximately 2.7 hours explains why this schedule works — the drug stays active long enough to support that interval.

Titration: Why Starting Low Matters

For this class of compound, gradual titration is the standard approach. The starting doses listed above are not therapeutic — they exist to let the body adapt and to reduce gastrointestinal symptoms .

A typical titration plan for PT-141 holds each dose step for at least four weeks before moving up. Faster titration is associated with more dropouts due to side effects.

Missed Doses

If a dose of PT-141 is missed: for daily schedules, the rule of thumb is to take it as soon as remembered if within a defined window, otherwise skip it and resume the regular schedule. The exact window depends on the half-life (approximately 2.7 hours) and the specific product label. Never double up to make up for a missed dose.

Dose Adjustments

Dose adjustments may be needed for the following:

• Significant weight loss or weight gain
• Side-effect intolerance at the current step
• Changes in renal or hepatic function
• Drug interactions (particularly relevant for any concurrent medications)

We cover the side-effect side of dose decisions in PT-141 side effects and the cost angle of dose escalation in PT-141 cost.

What the Trials Used

Published trial data for PT-141 comes primarily from: RECONNECT trials (Kingsberg 2019, Obstet Gynecol) — improved desire scores in premenopausal women with HSDD.

That data drives the labeled dosing range, which is what physicians prescribe by.

Special Populations

The dosing guidance above applies to general adult use. Special populations — pregnancy, pediatric, severe renal impairment, hepatic dysfunction, elderly with frailty — require individualized assessment that this page can't substitute for.

For PT-141: the standard contraindications for this drug class apply.

Bottom Line

PT-141 dosing isn't intuitive but it isn't complicated either. Follow the schedule, talk to your prescriber when something feels off, and don't make changes on your own.

Frequently Asked Questions

Related Reading

• Is PT-141 Right for You? An Evidence-Based Breakdown
• What Nobody Tells You About PT-141 Side Effects
• PT-141 Results: Realistic Expectations vs. Trial Headlines
• Why PT-141 Costs So Much (and 5 Ways to Pay Less)
• hCG: The Complete 2026 Guide (Mechanism, Dosing, Cost)
• What Is Oxytocin? Everything You Should Know Before Starting

Sources

• Skorupskaite K et al. Kisspeptin and Reproduction in Humans. Hum Reprod Update 2014;20:485.
• Kingsberg SA et al. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder. Obstet Gynecol 2019;134:899.

This page is informational only and is not medical advice. Always follow your prescribing clinician's dosing instructions.